Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.54 |
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.49 |
| ▸ | GSK3A | P49840 | 2/20 | 0.49 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21350964 | 1.00 | HINT1 (0.56) | HINT1HPGDSLC29A1NT5EPNP | |
| SCHEMBL25101228 | 0.91 | HINT1 (0.54) | HINT1HPGDSLC29A1NT5EPNP | |
| SCHEMBL23813665 | 0.91 | HINT1 (0.54) | HINT1HPGDSLC29A1NT5EPNP | |
| SCHEMBL23813628 | 0.89 | HPGD (0.59) | HINT1HPGDNT5EPNPGSK3A | |
| SCHEMBL21350965 | 0.89 | HPGD (0.59) | HINT1HPGDNT5EPNPGSK3A | |
| SCHEMBL23813667 | 0.87 | HINT1 (0.56) | HINT1HPGDSLC29A1NT5EPNP | |
| SCHEMBL25101227 | 0.87 | HINT1 (0.56) | HINT1HPGDSLC29A1NT5EPNP | |
| SCHEMBL23813664 | 0.87 | HPGD (0.59) | HINT1HPGDNT5EPNPGSK3A | |
| SCHEMBL21350960 | 0.87 | HPGD (0.59) | HINT1HPGDNT5EPNPGSK3A | |
| Guanosine SCHEMBL28343812 | 0.85 | HPGD (0.69) | HINT1HPGDNT5EPNPADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284679-A1 | ß-Modified Phosphoric Acid Compound Precursor, ß-Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284679-A1 | ß-Modified Phosphoric Acid Compound Precursor, ß-Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction | IRS1, PPM1A, PPM1G | HINT1 558/4885HPGD 4639/4885SLC29A1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.